Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
28,919,953
-
Share change
-
-4,683,920
-
Total reported value
-
$79,256,000
-
Price per share
-
$2.74
-
Number of holders
-
62
-
Value change
-
-$19,556,970
-
Number of buys
-
26
-
Number of sells
-
34
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q1 2022
As of 31 Mar 2022,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,919,953 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Pivotal bioVenture Partners Investment Advisor LLC, BlackRock Inc., Nan Fung Group Holdings Ltd, Holocene Advisors, LP, and Samsara BioCapital, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.